Compare KOF & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOF | GEHC |
|---|---|---|
| Founded | 1979 | 1892 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.4B | 27.9B |
| IPO Year | 1998 | 2022 |
| Metric | KOF | GEHC |
|---|---|---|
| Price | $110.71 | $63.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $111.00 | $88.38 |
| AVG Volume (30 Days) | 107.5K | ★ 2.4M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.47% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $7.55 | $7.12 |
| Revenue Next Year | $6.69 | $4.45 |
| P/E Ratio | ★ $18.35 | $76.67 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $80.23 | $58.75 |
| 52 Week High | $117.09 | $89.77 |
| Indicator | KOF | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 29.34 |
| Support Level | $103.23 | $60.17 |
| Resistance Level | $116.72 | $65.83 |
| Average True Range (ATR) | 2.37 | 1.44 |
| MACD | -0.57 | -1.19 |
| Stochastic Oscillator | 21.07 | 8.18 |
Coca-Cola Femsa, a subsidiary of Femsa, is the largest franchise bottler of Coca-Cola in volume terms. The company purchases beverage concentrates and syrup from Coca-Cola, which it then processes and packages for distribution through modern trade, traditional trade, and the on-premises channel. Mexico and Brazil make up 80% of the total volume and sales, with the rest from other Central and South American countries, including Panama, Guatemala, Uruguay, and Argentina. Femsa and Coca-Cola hold 47% and 28% economic interests in Coca-Cola Femsa through nonpublicly traded A and D shares, respectively, while controlling 56% and 33% of the voting power.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).